Literature DB >> 8266402

Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic.

E D Johnson1, J P Gonzalez, A Georges.   

Abstract

Seroepidemiological surveys were conducted to determine the frequency and distribution of haemorrhagic fever virus (HFV) activity in the Central African Republic. Human serum specimens (4295) were collected from 5 ecologically distinct zones. Serological evidence of HFV activity was found in all the zones. The filovirus antibody prevalence (24.4%, 1051/4295) was greater than the combined prevalence for Lassa virus, Rift Valley fever virus and Crimean-Congo HFV antibody (1.1%, 45/4295; P < 0.01). Evidence of filovirus activity was found in all zones: 21.3% (914/4295) of the population were seropositive for Ebola virus antibody while only 3.2% (137/4295) were seroreactive with Marburg viral antigens. Age and sex were important host-related factors influencing filovirus activity, particularly in dry grassland and moist forest communities. These communities shared many factors, but differences, such as agricultural practices and ethnic backgrounds, may also affect the risk of infection. Filovirus infections appear to occur without apparent disease. Continued investigations are needed to evaluate the true pathogenicity of the African filoviruses and the likelihood that unidentified serologically cross-reacting and non-pathogenic members of the filovirus family are active in equatorial Africa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266402     DOI: 10.1016/0035-9203(93)90075-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  11 in total

1.  Mapping a Filoviral Serologic Footprint in the Democratic Republic of the Congo: Who Goes There?

Authors:  Ian Crozier
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

2.  Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.

Authors:  Anna Bratcher; Nicole A Hoff; Reena H Doshi; Adva Gadoth; Megan Halbrook; Patrick Mukadi; Kamy Musene; Benoit Ilunga-Kebela; D'Andre Spencer; Matthew S Bramble; David McIlwan; J Daniel Kelly; Daniel Mukadi; Placide Mbala Kingebeni; Steve Ahuka; Emile Okitolonda-Wemakoy; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  PLoS Negl Trop Dis       Date:  2021-08-12

3.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

Review 4.  Mapping the zoonotic niche of Marburg virus disease in Africa.

Authors:  David M Pigott; Nick Golding; Adrian Mylne; Zhi Huang; Daniel J Weiss; Oliver J Brady; Moritz U G Kraemer; Simon I Hay
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-03-27       Impact factor: 2.184

5.  Integrated biological-behavioural surveillance in pandemic-threat warning systems.

Authors:  Maureen Miller; Emily Hagan
Journal:  Bull World Health Organ       Date:  2016-11-03       Impact factor: 9.408

Review 6.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

Review 7.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection.

Authors:  Hilary Bower; Judith R Glynn
Journal:  Sci Data       Date:  2017-01-31       Impact factor: 6.444

8.  A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.

Authors:  Luke Nyakarahuka; Ilana J Schafer; Stephen Balinandi; Sophia Mulei; Alex Tumusiime; Jackson Kyondo; Barbara Knust; Julius Lutwama; Pierre Rollin; Stuart Nichol; Trevor Shoemaker
Journal:  BMC Infect Dis       Date:  2020-07-01       Impact factor: 3.090

9.  Serologic Prevalence of Ebola Virus in Equatorial Africa.

Authors:  Imke Steffen; Kai Lu; Lauren K Yamamoto; Nicole A Hoff; Prime Mulembakani; Emile O Wemakoy; Jean-Jacques Muyembe-Tamfum; Nicaise Ndembi; Catherine A Brennan; John Hackett; Susan L Stramer; William M Switzer; Sentob Saragosti; Guy O Mbensa; Syria Laperche; Anne W Rimoin; Graham Simmons
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

10.  Development of a highly sensitive, field operable biosensor for serological studies of Ebola virus in central Africa.

Authors:  A Petrosova; T Konry; S Cosnier; I Trakht; J Lutwama; E Rwaguma; A Chepurnov; E Mühlberger; L Lobel; R S Marks
Journal:  Sens Actuators B Chem       Date:  2006-08-14       Impact factor: 7.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.